{"organizations": [], "uuid": "7ed421bf1dbae679332858ae7e313cb9be9248e3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180525.html", "section_title": "Archive News &amp; Video for Friday, 25 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/sun-pharm-results/indias-sun-pharma-industries-q4-profit-up-7-pct-beats-estimates-idUSL3N1SW3SE", "country": "US", "domain_rank": 408, "title": "India's Sun Pharma Industries Q4 profit up 7 pct, beats estimates", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-25T18:27:00.000+03:00", "replies_count": 0, "uuid": "7ed421bf1dbae679332858ae7e313cb9be9248e3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/sun-pharm-results/indias-sun-pharma-industries-q4-profit-up-7-pct-beats-estimates-idUSL3N1SW3SE", "ord_in_thread": 0, "title": "India's Sun Pharma Industries Q4 profit up 7 pct, beats estimates", "locations": [], "entities": {"persons": [{"name": "subhranshu sahu", "sentiment": "none"}, {"name": "arnab paul", "sentiment": "none"}], "locations": [{"name": "india", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "sun pharmaceutical industries ltd", "sentiment": "negative"}, {"name": "sun pharma industries", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 25 (Reuters) - Sun Pharmaceutical Industries Ltd , Indiaâ€™s largest drugmaker, posted fourth-quarter net profit way above expectations.\nNet profit rose 7 percent to 13.09 billion rupees ($193.15 million) in the three months ended March 31, from 12.24 billion rupees in the year-ago quarter, the company said here on Friday.\nAnalysts on average expected a net profit of 9.47 billion rupees, according to Thomson Reuters data.\nTotal revenue from operations declined 1.6 percent to 67.11 billion rupees. ($1 = 67.7700 Indian rupees) (Reporting By Arnab Paul in Bengaluru; Editing by Subhranshu Sahu)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.bseindia.com/xml-data/corpfiling/AttachLive/27073f65-5391-4c76-b636-bef219a6b724.pdf", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-25T18:27:00.000+03:00", "crawled": "2018-05-26T20:33:06.001+03:00", "highlightTitle": ""}